These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14204420)

  • 1. THE IMPACT OF THE NEW FOOD AND DRUG LAWS AND REGULATIONS ON THE SPONSORS OF CLINICAL TRIALS.
    HEIN JW
    J Oral Ther Pharmacol; 1964 Jul; 1():85-92. PubMed ID: 14204420
    [No Abstract]   [Full Text] [Related]  

  • 2. INVESTIGATIONAL DRUG REGULATIONS AND CLINICAL RESEARCH.
    GIBSON ML
    J Oral Ther Pharmacol; 1964 Jul; 1():93-8. PubMed ID: 14204421
    [No Abstract]   [Full Text] [Related]  

  • 3. THE IMPACT OF RECENT REGULATIONS OF THE FEDERAL FOOD AND DRUG ADMINISTRATION ON CLINICAL INVESTIGATION OF NEW DRUGS IN DENTISTRY: THE VIEW OF THE CLINICAL INVESTIGATOR.
    KUTSCHER AH; ZEGARELLI EV
    J Oral Ther Pharmacol; 1964 Jul; 1():79-84. PubMed ID: 14204418
    [No Abstract]   [Full Text] [Related]  

  • 4. THE NEW DRUG REGULATIONS AND THE PHARMACEUTICAL INDUSTRY.
    KIRSCH WE
    Proc West Pharmacol Soc; 1963; 6():48-52. PubMed ID: 14062834
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS and drug pricing: in search of a policy.
    Salbu SR
    Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750
    [No Abstract]   [Full Text] [Related]  

  • 6. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 7. LEGAL AND ETHICAL ASPECTS OF EXPERIMENTAL DRUG DISTRIBUTION AND RETRIEVAL.
    BALLARD RW; COOPER WA; WILLIG SH
    J New Drugs; 1965; 5(2):72-7. PubMed ID: 14315153
    [No Abstract]   [Full Text] [Related]  

  • 8. [DRUG LAWS IN THE GERMAN DEMOCRATIC REPUBLIC].
    RUCKPAUL K; STOPP G
    Dtsch Gesundheitsw; 1964 Jun; 19():1126-8. PubMed ID: 14233023
    [No Abstract]   [Full Text] [Related]  

  • 9. WASHINGTON AND NEW DRUGS. NEW REGULATIONS REQUIRE FILING OF SAFETY AND EFFICACY DATA FOR NEW DRUGS INTRODUCED SINCE 1938.
    LARRICK GP
    J New Drugs; 1964; 4(2):105-10. PubMed ID: 14197104
    [No Abstract]   [Full Text] [Related]  

  • 10. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.
    WESTON JK; WESTON K
    Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685
    [No Abstract]   [Full Text] [Related]  

  • 11. HOW THE FOOD AND DRUG ADMINISTRATION EVALUATES NEW DRUG APPLICATIONS.
    LARRICK GP
    J New Drugs; 1964; 4(2):63-74. PubMed ID: 14197105
    [No Abstract]   [Full Text] [Related]  

  • 12. Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007.
    Meron D
    Seton Hall Law Rev; 2007; 37(4):929-39. PubMed ID: 18363219
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 14. PROBLEMS IN DRUG DEVELOPMENT AS THEY RELATE TO THE GOVERNMENT.
    PISANI JM
    J New Drugs; 1964; 4(6):318-21. PubMed ID: 14247773
    [No Abstract]   [Full Text] [Related]  

  • 15. Criminal liability for misconduct in scientific research.
    Kuzma SM
    Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE NEW DRUG LAW OF THE GERMAN DEMOCRATIC REPUBLIC].
    BERTLING D
    Pharm Prax; 1964; 11():177-80. PubMed ID: 14328549
    [No Abstract]   [Full Text] [Related]  

  • 17. Legal aspects of regulations pertaining to sale and distribution of analytical standards for drugs of abuse. I.
    Evans JG
    J Chromatogr Sci; 1972 May; 10(5):342-6. PubMed ID: 5066301
    [No Abstract]   [Full Text] [Related]  

  • 18. The evaluation of new drugs. Current Food and drug Administration regulations and statistical aspects of clinical trials.
    Barron BA; Bukantz SC
    Arch Intern Med; 1967 Jun; 119(6):547-56. PubMed ID: 6027182
    [No Abstract]   [Full Text] [Related]  

  • 19. [CRITICISM OF THE DRUG LAW. (1)].
    HARDERWIJK ED
    Pharm Weekbl; 1964 Feb; 99():229-34. PubMed ID: 14139144
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.